Related Experiment Video
Updated: Feb 16, 2026

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
Published on: August 29, 2016
Hepatic progenitor cell activation in liver repair
Adam Bria1, Jorgessen Marda1, Junmei Zhou1
1Pediatric Stem Cell Research and Hepatic Disorders, Child Health Research Institute, Department of Pediatrics, University of Florida, Gainesville, FL, USA.
Liver regeneration relies on hepatocytes, but hepatic progenitor cells (HPCs) activate when hepatocyte replication is blocked. Understanding HPC activation is key for developing anti-fibrotic therapies.
Area of Science:
- Hepatology and Regenerative Medicine
- Cell Biology
- Molecular Biology
Background:
- The liver has a remarkable capacity for regeneration following injury.
- Hepatocyte proliferation is the primary response to mild acute liver damage.
- Facultative hepatic progenitor cells (HPCs), or oval cells (OCs) in rodents, are activated when mature hepatocyte replication is impaired.
Purpose of the Study:
- To investigate the role and activation mechanisms of hepatic progenitor cells (HPCs) in liver regeneration and disease.
- To explore the association between HPC/OC activation and fibrotic responses in chronic liver conditions.
- To identify molecular targets for anti-fibrotic therapies by understanding HPC/OC regulation.
Main Methods:
- Review of conserved liver injury response mechanisms across species.
- Analysis of the role of matrix remodeling and metalloproteases in HPC/OC function.
- Investigation of molecular pathways governing HPC/OC proliferation and differentiation.
Main Results:
- HPCs/OCs are crucial for liver regeneration when hepatocyte replication is blocked.
- HPC/OC activation is conserved across various species, including mammals and fish.
- Improper HPC/OC activation correlates with fibrosis development, involving myofibroblast activation and extracellular matrix deposition.
Conclusions:
- HPC/OC activation is a critical, conserved liver repair mechanism.
- Dysregulated HPC/OC activity contributes to liver fibrosis progression.
- Targeting molecular mechanisms of HPC/OC activation offers potential for novel anti-fibrotic treatments.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Mismatch Repair
Overview of DNA Repair
Chemically...
Base Excision Repair
The first step of...
Nucleotide Excision Repair
Long-patch Base Excision Repair

